Literature DB >> 25170395

Pathophysiology, clinical features and radiological findings of differentiation syndrome/all-trans-retinoic acid syndrome.

Luciano Cardinale1, Francesco Asteggiano1, Federica Moretti1, Federico Torre1, Stefano Ulisciani1, Carmen Fava1, Giovanna Rege-Cambrin1.   

Abstract

In acute promyelocytic leukemia, differentiation therapy based on all-trans-retinoic acid can be complicated by the development of a differentiation syndrome (DS). DS is a life-threatening complication, characterized by respiratory distress, unexplained fever, weight gain, interstitial lung infiltrates, pleural or pericardial effusions, hypotension and acute renal failure. The diagnosis of DS is made on clinical grounds and has proven to be difficult, because none of the symptoms is pathognomonic for the syndrome without any definitive diagnostic criteria. As DS can have subtle signs and symptoms at presentation but progress rapidly, end-stage DS clinical picture resembles the acute respiratory distress syndrome with extremely poor prognosis; so it is of absolute importance to be conscious of these complications and initiate therapy as soon as it was suspected. The radiologic appearance resembles the typical features of cardiogenic pulmonary edema. Diagnosis of DS remains a great skill for radiologists and haematologist but it is of an utmost importance the cooperation in suspect DS, detect the early signs of DS, examine the patients' behaviour and rapidly detect the complications.

Entities:  

Keywords:  Acute promyelocytic leukaemia; All-trans-retinoic acid syndrome; Chest X-ray and computed tomography; Differentiation syndrome; Lungleukemic infiltrates; Promyelocytic leukemia/retinoic acid receptor-α

Year:  2014        PMID: 25170395      PMCID: PMC4147438          DOI: 10.4329/wjr.v6.i8.583

Source DB:  PubMed          Journal:  World J Radiol        ISSN: 1949-8470


  26 in total

1.  Radiologic features of all-trans-retinoic acid syndrome.

Authors:  Jung Im Jung; Jung Eun Choi; Seong Tai Hahn; Chang Ki Min; Chun Choo Kim; Seog Hee Park
Journal:  AJR Am J Roentgenol       Date:  2002-02       Impact factor: 3.959

2.  DNA topoisomerase II in therapy-related acute promyelocytic leukemia.

Authors:  Anita R Mistry; Carolyn A Felix; Ryan J Whitmarsh; Annabel Mason; Andreas Reiter; Bruno Cassinat; Anne Parry; Christoph Walz; Joseph L Wiemels; Mark R Segal; Lionel Adès; Ian A Blair; Neil Osheroff; Andrew J Peniket; Marina Lafage-Pochitaloff; Nicholas C P Cross; Christine Chomienne; Ellen Solomon; Pierre Fenaux; David Grimwade
Journal:  N Engl J Med       Date:  2005-04-14       Impact factor: 91.245

3.  Retinoic acid syndrome: pulmonary computed tomography (CT) findings.

Authors:  B A Davis; P Cervi; Z Amin; G Moshi; P Shaw; J Porter
Journal:  Leuk Lymphoma       Date:  1996-09

4.  Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome.

Authors:  M S Tallman; J W Andersen; C A Schiffer; F R Appelbaum; J H Feusner; A Ogden; L Shepherd; J M Rowe; C François; R S Larson; P H Wiernik
Journal:  Blood       Date:  2000-01-01       Impact factor: 22.113

Review 5.  Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet.

Authors:  Miguel A Sanz; David Grimwade; Martin S Tallman; Bob Lowenberg; Pierre Fenaux; Elihu H Estey; Tomoki Naoe; Eva Lengfelder; Thomas Büchner; Hartmut Döhner; Alan K Burnett; Francesco Lo-Coco
Journal:  Blood       Date:  2008-09-23       Impact factor: 22.113

6.  Clinicobiological features and outcome of acute promyelocytic leukemia occurring as a second tumor: the GIMEMA experience.

Authors:  Alessandro Pulsoni; Livio Pagano; Francesco Lo Coco; Giuseppe Avvisati; Luca Mele; Eros Di Bona; Rosangela Invernizzi; Franco Leoni; Filippo Marmont; Alfonso Mele; Lorella Melillo; Anna Maria Nosari; Enrico Maria Pogliani; Marco Vignetti; Giuseppe Visani; Vittorina Zagonel; Giuseppe Leone; Franco Mandelli
Journal:  Blood       Date:  2002-09-15       Impact factor: 22.113

Review 7.  Acute promyelocytic leukemia: from highly fatal to highly curable.

Authors:  Zhen-Yi Wang; Zhu Chen
Journal:  Blood       Date:  2008-03-01       Impact factor: 22.113

8.  Reduction of pulmonary toxicity by prednisolone prophylaxis during all-trans retinoic acid treatment of acute promyelocytic leukemia. Australian Leukaemia Study Group.

Authors:  J S Wiley; F C Firkin
Journal:  Leukemia       Date:  1995-05       Impact factor: 11.528

9.  Chemokine induction by all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia: triggering the differentiation syndrome.

Authors:  Maaike Luesink; Jeroen L A Pennings; Willemijn M Wissink; Peter C M Linssen; Petra Muus; Rolph Pfundt; Theo J M de Witte; Bert A van der Reijden; Joop H Jansen
Journal:  Blood       Date:  2009-10-14       Impact factor: 22.113

10.  Role of all-trans-retinoic acid (ATRA) in the consolidation therapy of acute promyelocytic leukaemia (APL).

Authors:  Vikas Gupta; Qi-long Yi; Joseph Brandwein; Jeffrey H Lipton; Hans A Messner; Andre C Schuh; Richard A Wells; Mark D Minden
Journal:  Leuk Res       Date:  2005-01       Impact factor: 3.156

View more
  7 in total

Review 1.  Current first- and second-line treatment options in acute promyelocytic leukemia.

Authors:  Fulvio Massaro; Matteo Molica; Massimo Breccia
Journal:  Int J Hematol Oncol       Date:  2017-02-02

Review 2.  Enasidenib: First Global Approval.

Authors:  Esther S Kim
Journal:  Drugs       Date:  2017-10       Impact factor: 11.431

3.  HMGB1 promotes differentiation syndrome by inducing hyperinflammation via MEK/ERK signaling in acute promyelocytic leukemia cells.

Authors:  Lanlan Tang; Wenwen Chai; Fanghua Ye; Yan Yu; Lizhi Cao; Minghua Yang; Min Xie; Liangchun Yang
Journal:  Oncotarget       Date:  2017-04-18

4.  Chemotherapy-induced pulmonary complications in cancer: Significance of clinicoradiological correlation.

Authors:  Ekta Dhamija; Pankaj Meena; Vidyasagar Ramalingam; Ranjeet Sahoo; Sameer Rastogi; Sanjay Thulkar
Journal:  Indian J Radiol Imaging       Date:  2020-03-30

5.  Efficacy and the Adverse Effects of Oral Versus Intravenous Arsenic for Acute Promyelocytic Leukemia: A Meta-Analysis of Randomized-Controlled Studies.

Authors:  Natthaporn Sasijareonrat; Nikolaus Jahn; Patompong Ungprasert; Weerapat Owattanapanich
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

6.  Multidisciplinary corroboration in differentiation syndrome: a case report.

Authors:  Sayan Sarkar; Priya Ghosh; Anisha Gehani; Niharendu Ghara; Parthasarathi Bhattacharyya
Journal:  J Med Case Rep       Date:  2021-05-05

7.  A comparative study of anti-leukemic effects of kaempferol and epigallocatechin-3-gallate (EGCG) on human leukemia HL-60 cells.

Authors:  Mohammad Hassan Jokar; Sima Sedighi; Maliheh Moradzadeh
Journal:  Avicenna J Phytomed       Date:  2021 Jul-Aug
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.